All opioid-containing products which are given via oral route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)

All opioid-containing products which are given via oral route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)

All opioid-containing products which are given via parenteral route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)

All opioid-containing products which are given via parenteral route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)

All opioid-containing products which are given via rectal route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)

All opioid-containing products which are given via rectal route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)

All opioid-containing products which are given via transdermal route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)

All opioid-containing products which are given via transdermal route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)

Surgical fasciotomy codes - for limbs only

Surgical post-operative washout + debridement codes

A list of clinical codes related to osteoarthritis.

This code list contains codes from the NHS dictionary of medicines and devices (dm+d) for a collection of antidepressants from the BNF Chapter 040304 known as Other Antidepressants. These medicines are all licensed for the treatment of depression. The following antidepressants from this chapter have been excluded: Flupenthixol, Levomilnacripan, Oxitriptan. See github discussion for further details. Trazodone and Mianserin (both from BNF Chapter 040301) have also been included in this codelist. This codelist does not contain Bupropion, because this is not licensed in the UK for depression.